Related Experiment Video

Updated: Jul 18, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

[Uniform programme in caring for patients with acute hepatic porphyria]

E Kostrzewska1, A Gregor, A Lipniacki

  • 1Poradnia i Pracownia Badań nad Porfiria Instytutu Hematologii i Transfuzjologii w Warszawie.

Polskie Archiwum Medycyny Wewnetrznej
|April 3, 2002
PubMed

Insights

A Ministry of Health program improved porphyria diagnosis and prophylaxis in Poland. This initiative reduced severe attacks and mortality, though regional centers require further funding.

Area of Science:

  • Medical Science
  • Public Health
  • Genetics

Context:

  • The Ministry of Health commissioned a comprehensive program to address porphyria in Poland.
  • Data from 1996-1998 formed the basis for program development and evaluation.
  • Porphyria diagnosis and management presented significant public health challenges.

Purpose:

  • To enhance the early diagnosis, treatment, and prophylaxis of porphyria.
  • To disseminate crucial information on porphyria to healthcare professionals and patients.
  • To establish accessible diagnostic methods and safe treatment guidelines.

Summary:

  • A booklet detailing porphyria diagnosis, treatment, and prophylaxis was distributed nationwide.
  • Simple diagnostic methods were introduced to hospital laboratories for early detection.
  • Lectures and publications aimed to educate medical staff and advance scientific understanding.

Impact:

  • Significant improvement in early clinical diagnosis and family prophylaxis of porphyria.
  • Reduction in the frequency of severe porphyria attacks and mortality rates.
  • Demonstrated the need for sustained financial support for regional diagnostic centers.

More Related Videos

Application of Hemostatic Devices in Laparoscopic Hepatectomy04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

Porcine Normothermic Isolated Liver Perfusion07:32

Porcine Normothermic Isolated Liver Perfusion

Published on: June 9, 2023

Related Concept Videos

Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...